Welcome to the DREAMS Trial website!
The DREAMS trial has now been funded by a grant from the Bowel Disease Research Foundation!
DREAMS - Dexamethasone Reduces Emesis After Major Gastrointestinal Surgery
DREAMS is now open at 16 UK sites and the first patient was randomised by the QE, Birmingham!
DREAMS is a double-blind, phase IV, multi-centre randomised controlled trial designed to determine if pre-operative dexamethasone reduces post-operative nausea and vomiting in patients undergoing elective colorectal resections.
The DREAMS study is the first trial of an investigational medicinal product (CTIMP) to be developed by the West Midlands Research Collaborative.
DREAMS Trial Synopsis